Patients will received Tekmira's TKM-Ebola
September 22, 2014 at 12:08 PM EDT
The
Food and Drug Administration has authorized Tekmira Pharmaceuticals
Corp. (Nasdaq: TKMR) to provide TKM-Ebola to treat patients with confirmed or
suspected Ebola infections. The stock price surged $2.95 to $23.11.